“Robert’s expertise in U.S. and international regulatory affairs has been invaluable to DIA as we have identified how best to advance regulatory science and actively involve regulators in the work of DIA.”
Washington, DC (PRWEB) June 04, 2015
Robert Paarlberg, MS, Principal, Paarlberg & Associates, LLC will be honored with a Regional Inspire Award for the Americas at DIA’s upcoming Annual Meeting. DIA’s Regional Inspire Awards program recognizes DIA’s outstanding volunteers for their leadership, level of excellence, and commitment to service.
Paarlberg will receive the Excellence in Service Award that recognizes an outstanding DIA member for exemplary service.
“Robert’s expertise in U.S. and international regulatory affairs has been invaluable to DIA as we have identified how best to advance regulatory science and actively involve regulators in the work of DIA,” said Susan Cantrell, senior vice president and managing director, DIA Americas. “We are grateful for his involvement in DIA and look forward to continued partnership to advance collaborative partnerships between stakeholders from both industry and regulatory agencies.”
Paarlberg founded Paarlberg & Associates, LLC in 2010, a consultancy specializing in global clinical trial disclosure strategy and operations, regulatory policy and regulatory intelligence. He has more than 35 years of pharmaceutical industry experience. In his previous position as director of Global Regulatory Policy & Intelligence at UCB, Inc., he set up and directed UCB’s first global regulatory policy and intelligence function and chaired UCB’s multi-disciplinary team tasked with interpretation of and compliance with the FDA Amendments Act of 2007 (FDAAA). Paarlberg currently serves as Chair of DIA’s Clinical Trial Disclosure Community and as a member of DIA’s Advisory Council for North America.
DIA’s annual Inspire Awards nominees must have a record of outstanding commitment to raising the level of health and wellbeing worldwide. For more information about DIA’s Inspire Award program, click here.
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.
DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, Africa and the Middle East (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan). For more information, visit our website at http://www.DIAGlobal.org or contact us via Twitter @DrugInfoAssn, LinkedIn or on Facebook.
ABOUT DIA’s 2015 ANNUAL MEETING
The DIA 2015 51st Annual Meeting brings together a 7,000+ community of life sciences professionals at all levels and across all disciplines from around the globe that are involved in the discovery, development and life cycle management of medical products. Follow Annual Meeting news on Twitter using #DIA2015.